Arias, H. R., Feuerbach, D., Schmidt, B., Heydenreich, M., Paz, C., & Ortells, M. O. (2018). Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes. Web
Citación estilo ChicagoArias, Hugo Rubén, Dominik Feuerbach, Bernd Schmidt, Matthias Heydenreich, Cristian Paz, and Marcelo Oscar Ortells. Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors With Higher Potency Compared to Human α3β4 and α7 Subtypes. 2018.
Cita MLAArias, Hugo Rubén, et al. Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors With Higher Potency Compared to Human α3β4 and α7 Subtypes. 2018.